TNF-α inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling

Tomoyuki Mukai, Fumio Otsuka, Hiroyuki Otani, Misuzu Yamashita, Koji Takasugi, Kenichi Inagaki, Masahiro Yamamura, Hirofumi Makino

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

The cellular mechanism by which TNF-α inhibits osteoblastic differentiation induced by BMPs was investigated using mouse myoblast C2C12 cells expressing functional BMP receptors and Smad signaling molecules except ALK-6. Osteoblast transformation in response to BMP-2 was morphologically suppressed by TNF-α. Expression of biological markers for osteoblasts including Runx2 and osteocalcin, alkaline phosphatase activity, and parathyroid hormone (PTH) responsiveness shown by PTH-induced cAMP production were readily activated by BMP-2, -4, -6, and -7. The BMP-induced osteoblastic phenotype was dose-dependently inhibited by TNF-α. BMP-induced Smad1,5,8 phosphorylation of C2C12 cells was suppressed by TNF-α signaling. In addition, cDNA array analysis showed an increased expression of inhibitory Smad6 by TNF-α. MAP kinase analysis showed that ERK1/ERK2 and SAPK/JNK phosphorylation were selectively activated by TNF-α regardless of the presence of BMP ligands. BMPs had no effect on expression levels of TNF type 1 and 2 receptors. Notably, inhibition of SAPK/JNK restored TNF-α effects on BMP-induced osteoblast differentiation demonstrated by Id-1-promoter activity as well as Runx2 and osteocalcin mRNA levels. Collectively, TNF-α elicits BMP-induced osteogenic inhibition by suppressing BMP-Smad signaling pathway, at least in part, through SAPK/JNK activation and Smad6 upregulation.

Original languageEnglish
Pages (from-to)1004-1010
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume356
Issue number4
DOIs
Publication statusPublished - May 18 2007

Fingerprint

Osteoblasts
Phosphorylation
Osteocalcin
Parathyroid Hormone
Bone Morphogenetic Protein Receptors
Myoblasts
Oligonucleotide Array Sequence Analysis
Alkaline Phosphatase
Phosphotransferases
Up-Regulation
Complementary DNA
Biomarkers
Chemical activation
Cells
Ligands
Phenotype
Messenger RNA
Molecules

Keywords

  • Bone morphogenetic protein (BMP)
  • C2C12
  • Mitogen-activated protein (MAP) kinase
  • Osteoblast
  • Tumor necrosis factor (TNF)-α

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

TNF-α inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. / Mukai, Tomoyuki; Otsuka, Fumio; Otani, Hiroyuki; Yamashita, Misuzu; Takasugi, Koji; Inagaki, Kenichi; Yamamura, Masahiro; Makino, Hirofumi.

In: Biochemical and Biophysical Research Communications, Vol. 356, No. 4, 18.05.2007, p. 1004-1010.

Research output: Contribution to journalArticle

Mukai, Tomoyuki ; Otsuka, Fumio ; Otani, Hiroyuki ; Yamashita, Misuzu ; Takasugi, Koji ; Inagaki, Kenichi ; Yamamura, Masahiro ; Makino, Hirofumi. / TNF-α inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. In: Biochemical and Biophysical Research Communications. 2007 ; Vol. 356, No. 4. pp. 1004-1010.
@article{5f65d67524e2414d820884bf9052341f,
title = "TNF-α inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling",
abstract = "The cellular mechanism by which TNF-α inhibits osteoblastic differentiation induced by BMPs was investigated using mouse myoblast C2C12 cells expressing functional BMP receptors and Smad signaling molecules except ALK-6. Osteoblast transformation in response to BMP-2 was morphologically suppressed by TNF-α. Expression of biological markers for osteoblasts including Runx2 and osteocalcin, alkaline phosphatase activity, and parathyroid hormone (PTH) responsiveness shown by PTH-induced cAMP production were readily activated by BMP-2, -4, -6, and -7. The BMP-induced osteoblastic phenotype was dose-dependently inhibited by TNF-α. BMP-induced Smad1,5,8 phosphorylation of C2C12 cells was suppressed by TNF-α signaling. In addition, cDNA array analysis showed an increased expression of inhibitory Smad6 by TNF-α. MAP kinase analysis showed that ERK1/ERK2 and SAPK/JNK phosphorylation were selectively activated by TNF-α regardless of the presence of BMP ligands. BMPs had no effect on expression levels of TNF type 1 and 2 receptors. Notably, inhibition of SAPK/JNK restored TNF-α effects on BMP-induced osteoblast differentiation demonstrated by Id-1-promoter activity as well as Runx2 and osteocalcin mRNA levels. Collectively, TNF-α elicits BMP-induced osteogenic inhibition by suppressing BMP-Smad signaling pathway, at least in part, through SAPK/JNK activation and Smad6 upregulation.",
keywords = "Bone morphogenetic protein (BMP), C2C12, Mitogen-activated protein (MAP) kinase, Osteoblast, Tumor necrosis factor (TNF)-α",
author = "Tomoyuki Mukai and Fumio Otsuka and Hiroyuki Otani and Misuzu Yamashita and Koji Takasugi and Kenichi Inagaki and Masahiro Yamamura and Hirofumi Makino",
year = "2007",
month = "5",
day = "18",
doi = "10.1016/j.bbrc.2007.03.099",
language = "English",
volume = "356",
pages = "1004--1010",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - TNF-α inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling

AU - Mukai, Tomoyuki

AU - Otsuka, Fumio

AU - Otani, Hiroyuki

AU - Yamashita, Misuzu

AU - Takasugi, Koji

AU - Inagaki, Kenichi

AU - Yamamura, Masahiro

AU - Makino, Hirofumi

PY - 2007/5/18

Y1 - 2007/5/18

N2 - The cellular mechanism by which TNF-α inhibits osteoblastic differentiation induced by BMPs was investigated using mouse myoblast C2C12 cells expressing functional BMP receptors and Smad signaling molecules except ALK-6. Osteoblast transformation in response to BMP-2 was morphologically suppressed by TNF-α. Expression of biological markers for osteoblasts including Runx2 and osteocalcin, alkaline phosphatase activity, and parathyroid hormone (PTH) responsiveness shown by PTH-induced cAMP production were readily activated by BMP-2, -4, -6, and -7. The BMP-induced osteoblastic phenotype was dose-dependently inhibited by TNF-α. BMP-induced Smad1,5,8 phosphorylation of C2C12 cells was suppressed by TNF-α signaling. In addition, cDNA array analysis showed an increased expression of inhibitory Smad6 by TNF-α. MAP kinase analysis showed that ERK1/ERK2 and SAPK/JNK phosphorylation were selectively activated by TNF-α regardless of the presence of BMP ligands. BMPs had no effect on expression levels of TNF type 1 and 2 receptors. Notably, inhibition of SAPK/JNK restored TNF-α effects on BMP-induced osteoblast differentiation demonstrated by Id-1-promoter activity as well as Runx2 and osteocalcin mRNA levels. Collectively, TNF-α elicits BMP-induced osteogenic inhibition by suppressing BMP-Smad signaling pathway, at least in part, through SAPK/JNK activation and Smad6 upregulation.

AB - The cellular mechanism by which TNF-α inhibits osteoblastic differentiation induced by BMPs was investigated using mouse myoblast C2C12 cells expressing functional BMP receptors and Smad signaling molecules except ALK-6. Osteoblast transformation in response to BMP-2 was morphologically suppressed by TNF-α. Expression of biological markers for osteoblasts including Runx2 and osteocalcin, alkaline phosphatase activity, and parathyroid hormone (PTH) responsiveness shown by PTH-induced cAMP production were readily activated by BMP-2, -4, -6, and -7. The BMP-induced osteoblastic phenotype was dose-dependently inhibited by TNF-α. BMP-induced Smad1,5,8 phosphorylation of C2C12 cells was suppressed by TNF-α signaling. In addition, cDNA array analysis showed an increased expression of inhibitory Smad6 by TNF-α. MAP kinase analysis showed that ERK1/ERK2 and SAPK/JNK phosphorylation were selectively activated by TNF-α regardless of the presence of BMP ligands. BMPs had no effect on expression levels of TNF type 1 and 2 receptors. Notably, inhibition of SAPK/JNK restored TNF-α effects on BMP-induced osteoblast differentiation demonstrated by Id-1-promoter activity as well as Runx2 and osteocalcin mRNA levels. Collectively, TNF-α elicits BMP-induced osteogenic inhibition by suppressing BMP-Smad signaling pathway, at least in part, through SAPK/JNK activation and Smad6 upregulation.

KW - Bone morphogenetic protein (BMP)

KW - C2C12

KW - Mitogen-activated protein (MAP) kinase

KW - Osteoblast

KW - Tumor necrosis factor (TNF)-α

UR - http://www.scopus.com/inward/record.url?scp=34047152284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047152284&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2007.03.099

DO - 10.1016/j.bbrc.2007.03.099

M3 - Article

VL - 356

SP - 1004

EP - 1010

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -